article thumbnail

Delaware Law Alert: Chancery Court Applies Conditional Probability to Calculate Damages in Earnout Dispute

JD Supra: Mergers

The case arose from Alexion Pharmaceuticals, Inc.’s s 2018 acquisition of Syntimmune, Inc. A recent Delaware Chancery Court opinion offers a significant example of how courts may apply complex probability analysis to determine the amount of damages in an earnout dispute.

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Great Point Acquires Eutecma

JD Supra: Mergers

Great Point Partners (GPP) has announced the acquisition of a majority stake in Eutecma. Eutecma, founded in 2008 and based in Germany, is a developer of temperature-controlled packaging solutions for pharmaceutical cold chain shipments. By: McGuireWoods LLP

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Energy & Sustainability M&A Activity — September 2024

JD Supra: Mergers

August 01, 2024: SEAM Group, a B2B business products and services company that provides safety, reliability, maintenance, and enterprise asset management services in the hospitality, food processing, and pharmaceutical industries, was acquired by ABB for an undisclosed amount.

M&A 171
article thumbnail

Boston Scientific to Acquire Axonics for $3.7 Billion

JD Supra: Mergers

Morgan Healthcare Conference in San Francisco, which also saw the announcement of major acquisitions by large players in the pharmaceutical space. The timing of the announcement coincided with the start of the 42nd Annual J.P. By: Knobbe Martens

article thumbnail

New UK Competition Rules to Impact Global Deal Reviews for Tech and Pharma

JD Supra: Mergers

The UK DMCC forms part of a global trend to focus merger review increasingly on vertical concerns and concerns about eliminating nascent competition, including by so-called “killer acquisitions” of firms perceived as future competitive threats. The reforms are particularly relevant to the technology and pharmaceutical.

article thumbnail

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

Global Newswire by Notified: M&A

16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” ANI” or “the Company”) (Nasdaq: ANIP) today announced the completion of its previously announced acquisition of Alimera Sciences, Inc. PRINCETON, N.J., Nasdaq: ALIM) (“Alimera”).

article thumbnail

Amgen-Horizon: The FTC's First Litigated Pharmaceutical Merger Challenge in 14 Years and First Conglomerate Merger Challenge in Decades

JD Supra: Mergers

s (Amgen) proposed acquisition of Horizon Therapeutics plc (Horizon). On May 17, 2023, the Federal Trade Commission (FTC) challenged Amgen Inc.’s The complaint is significant in three respects. By: Wilson Sonsini Goodrich & Rosati